However, the positive associations between genetic variation in the target of GLP-1 receptor agonists and all obesity-related phenotypes were inconsistent with existing evidence that GLP-1 receptor agonists have a weight loss effect. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.